0001012975-16-001176.txt : 20160422
0001012975-16-001176.hdr.sgml : 20160422
20160422113631
ACCESSION NUMBER: 0001012975-16-001176
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160422
DATE AS OF CHANGE: 20160422
EFFECTIVENESS DATE: 20160422
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clarus Ventures, LLC
CENTRAL INDEX KEY: 0001431431
IRS NUMBER: 202234539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16028
FILM NUMBER: 161585895
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2200
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001431431
XXXXXXXX
03-31-2016
03-31-2016
Clarus Ventures, LLC
101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-16028
N
Robert W. Liptak
Managing Director
617-949-2200
/s/ Robert W. Liptak
Cambridge
MA
04-22-2016
0
6
133202
false
INFORMATION TABLE
2
clarus.xml
Oxford Immunotec Global PLC
COM
G6855A103
21337
2153092
SH
DFND
2153092
0
0
VBI Vaccines Inc.
COM
91790E102
12157
5173013
SH
DFND
5173013
0
0
Sientra Inc.
COM
82621J105
18678
2730765
SH
DFND
2730765
0
0
Nanostring Technologies Inc.
COM
63009R109
60263
3959440
SH
DFND
3959440
0
0
Catabasis Pharmaceuticals Inc.
COM
14875P107
13873
2752488
SH
DFND
2752488
0
0
ESSA Pharma Inc.
COM
29668H104
6894
2121212
SH
DFND
2121212
0
0